Modular Medical Launches PivotPump.com to Support Insulin Pump Therapy
Modular Medical announced the launch of PivotPump.com, a patient-focused website designed to support individuals seeking a simpler path to insulin pump therapy. This launch follows the Company's receipt of U.S. Food and Drug Administration clearance in April 2026 for its Pivot insulin delivery system. The FDA clearance represents a significant milestone in Modular Medical's strategy to expand access to insulin pump technology, particularly among individuals historically underserved by existing solutions. The Company remains on track for commercial launch in the fall of 2026. Pivot is designed for people living with diabetes who rely on daily insulin injections, as well as those who have encountered technological, usability, or cost-related barriers with traditional pump systems. The system emphasizes simplicity and ease of use for the patient and full access to clinical information for the clinician to reduce adoption friction. The PivotPump.com website provides accessible, educational content on insulin pump therapy and highlights the Company's focus on real-world usability and supporting patients in evaluating and adopting pump-based diabetes care.
